Singapore markets close in 1 hour 18 minutes

Straits Times Index
3,301.23
-1.96(-0.06%)
Nikkei
38,835.10
+599.03(+1.57%)
Hang Seng
18,484.57
-93.73(-0.50%)
FTSE 100
8,293.66
+80.17(+0.98%)
Bitcoin USD
63,762.95
-686.84(-1.07%)
CMC Crypto 200
1,368.62
+3.49(+0.26%)

BCRX Jan 2025 8.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.5000

0.0000

(0.00%)

As of 03:55PM EDT. Market open.

GuruFocus.com
BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
Discover how BioCryst Pharmaceuticals Inc (BCRX) navigated the first quarter of 2024, with detailed financial results and strategic updates.
Thomson Reuters StreetEvents
Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
Benzinga
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Monday, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a first-quarter earnings loss of $(0.17) per share versus the consensus estimate loss of $(0.21) per share and $(0.28) reported a year ago. BioCryst Pharma reported sales of $92.8 million, beating the consensus of $85.61 million. The sales increased 34.9% Y/Y, primarily due to $88.9 million in Orladeyo’s net revenue in the first quarter of 2024, up 30% Y/Y. “We are off to a fantastic start to the year with outstanding Orladeyo revenue g